Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Conference Coverage

Biosimilars: What Providers Need to Know
Conference Coverage
Biosimilars: What Providers Need to Know
07/12/2020
At IAS 2020, Jonathan Kay, MD, outlined the development, legislation, and economic aspects of biosimilars.
At IAS 2020, Jonathan Kay, MD, outlined the development, legislation, and economic aspects of biosimilars.
At IAS 2020, Jonathan Kay, MD,...
07/12/2020
Autoimmune
Improving and Tracking Inflammatory Arthritis Outcomes With Personal Technology
Conference Coverage
Improving and Tracking Inflammatory Arthritis Outcomes With Personal Technology
07/11/2020
Alexis Ogdie, MD, MSCE, discussed how technology designed to track physical and lifestyle goals can also be used to assess and manage patients with inflammatory arthritis at IAS 2020.
Alexis Ogdie, MD, MSCE, discussed how technology designed to track physical and lifestyle goals can also be used to assess and manage patients with inflammatory arthritis at IAS 2020.
Alexis Ogdie, MD, MSCE,...
07/11/2020
Autoimmune

Advertisement

Does Immunosuppressive Therapy Increase Risk of COVID-19 in Patients with IMID?
Conference Coverage
Does Immunosuppressive Therapy Increase Risk of COVID-19 in Patients with IMID?
07/11/2020
An expert panel at the Interdisciplinary Autoimmune Summit discussed the pros and cons of continuing biologic and small molecule therapy for patients with immune-mediated diseases during the pandemic, as well as when it’s right to stop...
An expert panel at the Interdisciplinary Autoimmune Summit discussed the pros and cons of continuing biologic and small molecule therapy for patients with immune-mediated diseases during the pandemic, as well as when it’s right to stop...
An expert panel at the...
07/11/2020
Autoimmune
What Specialists Need to Know About Immune-related Adverse Events From Cancer Immunotherapy
Conference Coverage
What Specialists Need to Know About Immune-related Adverse Events From Cancer Immunotherapy
07/10/2020
At the virtual IAS 2020, Leonard Calabrese, DO, discussed common immune-related adverse events caused by checkpoint inhibitors and the importance of a multidisciplinary approach to treat these patients.
At the virtual IAS 2020, Leonard Calabrese, DO, discussed common immune-related adverse events caused by checkpoint inhibitors and the importance of a multidisciplinary approach to treat these patients.
At the virtual IAS 2020, Leonard...
07/10/2020
Autoimmune
Dr Strand Reviews the Use of JAK Inhibitors for IMIDs
Conference Coverage
Dr Strand Reviews the Use of JAK Inhibitors for IMIDs
07/10/2020
Janus kinase inhibitors are the latest developments in the autoimmune treatment sphere. Vibeke Strand, MD, discussed their role in the treatment of various autoimmune diseases at IAS 2020.
Janus kinase inhibitors are the latest developments in the autoimmune treatment sphere. Vibeke Strand, MD, discussed their role in the treatment of various autoimmune diseases at IAS 2020.
Janus kinase inhibitors are the...
07/10/2020
Autoimmune

Advertisement

Exclusive Preview: Biosimilars for IMIDs: Availability, Affordability, and Interchangeability
Conference Coverage
Exclusive Preview: Biosimilars for IMIDs: Availability, Affordability, and Interchangeability
07/10/2020
In this short video from IAS 2020, Jonathan Kay, MD, summarizes why biosimilar use may be limited in the United States in his presentation, "Biosimilars for IMIDs: Availability, Affordability, and Interchangeability."
In this short video from IAS 2020, Jonathan Kay, MD, summarizes why biosimilar use may be limited in the United States in his presentation, "Biosimilars for IMIDs: Availability, Affordability, and Interchangeability."
In this short video from IAS...
07/10/2020
Autoimmune
Dr Chernoff Discusses the Promise of Vagus Nerve Stimulation for RA
Conference Coverage
Dr Chernoff Discusses the Promise of Vagus Nerve Stimulation for RA
07/10/2020
At IAS 2020, David Chernoff, MD, discussed the role of the vagus nerve and inflammatory reflex pathway in autoimmune diseases and how electrical stimulation may be a promising option for refractory disease.
At IAS 2020, David Chernoff, MD, discussed the role of the vagus nerve and inflammatory reflex pathway in autoimmune diseases and how electrical stimulation may be a promising option for refractory disease.
At IAS 2020, David Chernoff, MD,...
07/10/2020
Autoimmune
Exclusive Preview: Bioelectronic Medicine for Treatment of Rheumatoid Arthritis
Conference Coverage
Exclusive Preview: Bioelectronic Medicine for Treatment of Rheumatoid Arthritis
07/02/2020
David Chernoff, MD, introduces the concept of neuroimmune control of inflammation and its implications for treating patients with rheumatoid arthritis in this video preview of IAS 2020.
David Chernoff, MD, introduces the concept of neuroimmune control of inflammation and its implications for treating patients with rheumatoid arthritis in this video preview of IAS 2020.
David Chernoff, MD, introduces...
07/02/2020
Autoimmune

Advertisement

The New Virtual Meeting Experience: What to See at IAS
Conference Coverage
The New Virtual Meeting Experience: What to See at IAS
07/02/2020
The Interdisciplinary Autoimmune Summit 2020 virtual meeting will begin on July 10, 2020. Learn about the new virtual experience, including access to live and on-demand sessions.
The Interdisciplinary Autoimmune Summit 2020 virtual meeting will begin on July 10, 2020. Learn about the new virtual experience, including access to live and on-demand sessions.
The Interdisciplinary Autoimmune...
07/02/2020
Autoimmune
Dr Emma Guttman on IAS Virtual Meeting and Atopic Dermatitis
Conference Coverage
Dr Emma Guttman on IAS Virtual Meeting and Atopic Dermatitis
07/02/2020
Emma Guttman, MD, PhD, will present at this year’s virtual IAS meeting on the latest advances in atopic dermatitis.
Emma Guttman, MD, PhD, will present at this year’s virtual IAS meeting on the latest advances in atopic dermatitis.
Emma Guttman, MD, PhD, will...
07/02/2020
Autoimmune

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles
Quiz
Coexisting RA and AS
04/28/2021
The coexistence of rheumatoid arthritis and ankylosing spondylitis in one patient is rare, often leading to misdiagnosis. Take our quick quiz and find out which patients present key signs at onset.
The coexistence of rheumatoid arthritis and ankylosing spondylitis in one patient is rare, often leading to misdiagnosis. Take our quick quiz and find out which patients present key signs at onset.
The coexistence of rheumatoid...
04/28/2021
Autoimmune
A provider wearing a mask
Quiz
COVID-19 Outcomes and Patients With Vasculitis
12/30/2021
A quiz on the factors associated with severe COVID-19 outcomes among patients with vasculitis.
A quiz on the factors associated with severe COVID-19 outcomes among patients with vasculitis.
A quiz on the factors associated...
12/30/2021
Autoimmune
News
Immune Checkpoint Inhibitor-Associated Inflammatory Arthritis Can Last Months
04/08/2020
Immune checkpoint inhibitors have improved cancer outcomes but are associated with immune-related adverse events. Findings from a recent study highlighted the prevalence of and factors associated with immune checkpoint inhibitor-associated...
Immune checkpoint inhibitors have improved cancer outcomes but are associated with immune-related adverse events. Findings from a recent study highlighted the prevalence of and factors associated with immune checkpoint inhibitor-associated...
Immune checkpoint inhibitors...
04/08/2020
Autoimmune
News
Study Identifies Most Discriminative Ultrasound Lesions for Spondyloarthritis
09/11/2024
Active enthesitis was consistently linked with most clinical measures of spondyloarthritis disease activity and severity.
Active enthesitis was consistently linked with most clinical measures of spondyloarthritis disease activity and severity.
Active enthesitis was...
09/11/2024
Rheumatology & Arthritis
Alexis Ogdie
Podcast
Alexis Ogdie, MD, on Adverse Effects of Methotrexate in PsA
02/28/2023
Dr Ogdie discusses her research into the differences in reactions to methotrexate and tumor necrosis factor inhibitors among patients with psoriatic arthritis and rheumatoid arthritis.
Dr Ogdie discusses her research into the differences in reactions to methotrexate and tumor necrosis factor inhibitors among patients with psoriatic arthritis and rheumatoid arthritis.
Dr Ogdie discusses her research...
02/28/2023
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Stay In the Know

Autoimmune Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use